PON-mt-tRNA |
PON-mt-tRNA is a posterior probability-based method for classification of mitochondrial tRNA variations.
It integrates machine learning-based probability of pathogenicity and evidence-based likelihood of pathogenicity to predict the posterior probability of pathogenicity.
In absence of evidence, it classifies the variations based on the machine learning-based probability of pathogenicity.
It is trained and tested on variants classified as definitely pathogenic and definitely neutral by
Yarham et al..
|
'
![]() |
Home | About | Disclaimer | Datasets |
PON-mt-tRNAPON-mt-tRNA is a posterior probability-based tool for classification of human mitochondrial tRNA (mt-tRNA) variations. First it predicts the probability of pathogenicity using 20 machine learning (ML) predictors. Then, it uses the predicted probability as prior probability and integrates with the evidence submitted by the user. If no evidence is submitted, PON-mt-tRNA classifies the variations based on ML predicted probability. The ML predictors utilize features representing evolutionary conservation, sequence context, secondary structure and tertiary interactions. The method is trained by using variations that were classified previously by using evidence-based classification method by Yarham et al.. Balanced accuracy and Matthews correlation coefficient (MCC) for integrated classifier based on posterior probability are 0.99 and 0.95, respectively and for ML predictor based probability of pathogenicity are 0.81 and 0.56, respectively on independent test dataset. | ||||||||||||
Submit queries to PON-mt-tRNAmtDNA location and/or evidence PON-mt-tRNA requires variation location, and the reference and altered nucleotides separated by comma. In addition, the users can submit evidence of segregation, biochemical test and histochemical test which are optional. The evidence should be submitted in the following manner:
Note: The evidence should be submitted in the order Segregation, Biochemistry and Histochemistry. If evidence of Segregation is not known but others are known, NA should be used for segregation and then other should be provided. Multiple variations can be submitted in a single query. PON-mt-tRNA only classifies the single nucleotide substitutions and therefore does not accept other types of variations as input. Alternatively, a file containing the variations in the same format as described above can be uploaded. Example: DNA location,Reference nucleotide,New nucleotide[,Segregation[,Biochemistry,[Histochemistry]]] 618,T,C 7505,A,G,1 8300,T,C,NA,1,NA 7316,T,C,0,NA,1 7316,T,A,0,NA,0 7316,T,C,1,1,1 7316,T,A,NA,NA,NA 7316,T,C,0,0,0 Email Email field is obligatory. The predictions will be sent to you in the provided email address. | ||||||||||||
PON-mt-tRNA outputAn email with the result file as an attachment is sent to the email address provided during job submission. The result file contains the following contents: Prediction 1. mt-tRNA affected by the variation 2. Variation 3. ML probability of pathogenicity based on 20 ML predictors. It ranges from 0 to 1. 4.Evidence submitted by the user. 5. Posterior probability of pathogenicity after combining the ML predicted probability of pathogenicity and evidence submitted by the user. It ranges from 0 to 1. 6. Classification of variation. The classification is based on posterior probability if there is a posterior probability for the variation in column 5. Otherwise, the classification is based on ML predicted probability of pathogenicity in column 3. Other details 1. Column description 2. How to cite PON-mt-tRNA? 3. Disclaimer notice 4. Liability notice | ||||||||||||
Download PON-mt-tRNA predictionsWe classified all possible single nucleotide substitutions at each position in the 22 mt-tRNA using PON-mt-tRNA. The classification is based on ML predicted probability of pathogenicity. You can download the predictions using the following link. PON-mt-tRNA predictions | ||||||||||||
How to cite PON-mt-tRNA?
A manuscript describing PON-mt-tRNA has been accepted for publication. Please cite PON-mt-tRNA as.
Abhishek Niroula and Mauno Vihinen | ||||||||||||
If you have any queries, please feel free to contact us. |